Published in Hepatology on December 01, 2004
Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut (2006) 1.34
Factors influencing health-related quality of life in chronic liver disease. World J Gastroenterol (2006) 1.01
Assessment of health-related quality of life in antiviral-treated Taiwanese chronic hepatitis C patients using SF-36 and CLDQ. Health Qual Life Outcomes (2014) 0.88
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. World J Gastroenterol (2015) 0.87
The ongoing impacts of hepatitis c--a systematic narrative review of the literature. BMC Public Health (2012) 0.85
The effect of hepatitis C virus infection on health-related quality of life in prisoners. J Urban Health (2006) 0.84
Altered quality of life in the early stages of chronic hepatitis C is due to the virus itself. Clin Res Hepatol Gastroenterol (2013) 0.81
Home-based pulmonary rehabilitation program: Effect on exercise tolerance and quality of life in chronic obstructive pulmonary disease patients. Ann Thorac Med (2010) 0.81
Health-related quality of life in Greek chronic hepatitis C patients during pegylated interferon and ribavirin treatment. Hippokratia (2010) 0.81
Risk perception and priority setting for intervention among hepatitis C virus and environmental risks: a cross-sectional survey in the Cairo community. BMC Public Health (2010) 0.79
Socio-demographic and clinical features of Irish iatrogenic hepatitis C patients: a cross-sectional survey. BMC Public Health (2009) 0.77
Mode of transmission, rather than the hepatitis C virus, as a major determinant of poor interpersonal relationships in patients with chronic hepatitis C. Can J Gastroenterol (2007) 0.75
Hepatitis C and poor quality of life: is it the virus or the patient? Saudi J Gastroenterol (2008) 0.75
A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care (1996) 70.87
The Medical Outcomes Study. An application of methods for monitoring the results of medical care. JAMA (1989) 10.36
Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet (1997) 10.05
Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 10.03
Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med (1999) 6.50
Viral hepatitis C. Lancet (2003) 5.81
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet (2000) 5.44
Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health (2000) 3.82
The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.40
Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med (1999) 3.38
Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology (1998) 3.31
Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. JAMA (2003) 3.25
Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol (2000) 3.22
Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology (1999) 2.67
Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol (2003) 2.42
The impact of diagnosis of hepatitis C virus on quality of life. Hepatology (1999) 2.32
Comparison of the EQ-5D and SF-12 in an adult US sample. Qual Life Res (1998) 1.94
Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology (1999) 1.84
Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol (2001) 1.80
Are health-related quality-of-life measures affected by the mode of administration? J Clin Epidemiol (1996) 1.69
Modeling the hepatitis C virus epidemic in France. Hepatology (1999) 1.61
SF-36 scores vary by method of administration: implications for study design. J Public Health Med (1999) 1.51
Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus. J Hum Virol (1999) 1.50
The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol (2001) 1.50
Hepatitis C in asymptomatic blood donors. Hepatology (1997) 1.48
"They treated me like a leper". Stigmatization and the quality of life of patients with hepatitis C. J Gen Intern Med (2003) 1.47
Use of the 12-item short-form (SF-12) Health Survey in an Australian heart and stroke population. Qual Life Res (1999) 1.36
Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol (2001) 1.34
Empirically calibrated model of hepatitis C virus infection in the United States. Am J Epidemiol (2002) 1.26
Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood (2002) 1.22
Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther (1994) 1.20
Health assessment for chronic HCV infection: results of quality of life. Dig Dis Sci (1996) 1.20
Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J Hepatol (2002) 1.19
Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life. Dig Dis Sci (1997) 1.15
Infection with hepatitis B and C viruses, social class and cancer. IARC Sci Publ (1997) 1.14
A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual Life Res (1998) 1.11
Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C. Pharmacoeconomics (2003) 1.05
A psychometric comparison of health-related quality of life measures in chronic liver disease. J Clin Epidemiol (2001) 1.04
Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C. Am J Gastroenterol (2001) 1.02
The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain. Health Econ (2002) 1.00
Obtaining disability weights in rural Burkina Faso using a culturally adapted visual analogue scale. Health Econ (2002) 0.91
Labeling may be an important cause of reduced quality of life in chronic hepatitis C. Am J Gastroenterol (2003) 0.86
Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med (2011) 7.13
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. J Hepatol (2013) 5.64
Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS (2005) 5.51
Risk factors of influenza transmission in households. Br J Gen Pract (2004) 5.25
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet (2009) 5.03
Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet (2013) 4.57
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med (2011) 4.39
Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet (2013) 4.16
Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci U S A (2005) 3.37
Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology (2011) 3.08
Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA (2002) 2.91
Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology (2013) 2.78
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest (2010) 2.43
Influenza epidemics in the United States, France, and Australia, 1972-1997. Emerg Infect Dis (2004) 2.37
Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. J Acquir Immune Defic Syndr (2007) 2.32
Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J Hepatol (2005) 2.26
Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras. AIDS (2004) 2.11
Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob Agents Chemother (2010) 2.02
Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology (2012) 1.92
Risk factors for buruli ulcer: a case control study in Cameroon. PLoS Negl Trop Dis (2007) 1.90
Seasonal and regional dynamics of M. ulcerans transmission in environmental context: deciphering the role of water bugs as hosts and vectors. PLoS Negl Trop Dis (2010) 1.89
Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia. AIDS (2007) 1.88
Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut (2010) 1.87
Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial. J Am Geriatr Soc (2009) 1.87
Prediction of the spread of influenza epidemics by the method of analogues. Am J Epidemiol (2003) 1.85
Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV. AIDS (2006) 1.76
Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. Blood (2012) 1.73
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology (2005) 1.67
Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. Chest (2012) 1.66
Liver biopsy: the best, not the gold standard. J Hepatol (2008) 1.65
Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology (2006) 1.64
Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries. AIDS (2009) 1.60
Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. Gastroenterology (2002) 1.56
Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. J Hepatol (2010) 1.51
Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC Infect Dis (2010) 1.48
Demographic impact of AIDS in a low-fertility urban African setting: projection for Addis Ababa, Ethiopia. J Health Popul Nutr (2002) 1.46
Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010). Intensive Care Med (2014) 1.45
Hospitalization criteria in imported falciparum malaria. J Travel Med (2007) 1.45
Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler's diarrhea: a randomized, double-blind, controlled study. Clin Infect Dis (2006) 1.42
Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996-2003. Emerg Infect Dis (2007) 1.37
Mortality burden of the 1918-1919 influenza pandemic in Europe. Influenza Other Respir Viruses (2009) 1.35
Online detection and quantification of epidemics. BMC Med Inform Decis Mak (2007) 1.33
Feasibility of early infant diagnosis of HIV in resource-limited settings: the ANRS 12140-PEDIACAM study in Cameroon. PLoS One (2011) 1.30
Evolutionary relationships between bat coronaviruses and their hosts. Emerg Infect Dis (2007) 1.29
Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians. AIDS (2003) 1.29
Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS One (2012) 1.29
Geographic expansion of Buruli ulcer disease, Cameroon. Emerg Infect Dis (2011) 1.28
Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso. Am J Trop Med Hyg (2010) 1.28
ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog (2011) 1.26
Molecular monitoring of causative viruses in child acute respiratory infection in endemo-epidemic situations in Shanghai. J Clin Virol (2010) 1.22
Transmissibility and geographic spread of the 1889 influenza pandemic. Proc Natl Acad Sci U S A (2010) 1.22
Switch to second-line ART in West African routine care: incidence and reasons for switching. AIDS Care (2011) 1.19
Changing pattern of hepatitis C virus spread in rural areas of Egypt. J Hepatol (2005) 1.19
Severe imported Plasmodium falciparum malaria, France, 1996-2003. Emerg Infect Dis (2011) 1.15
Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia. PLoS One (2010) 1.15
Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era. PLoS One (2008) 1.14
Population modeling of influenza A/H1N1 virus kinetics and symptom dynamics. J Virol (2010) 1.14
Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors. AIDS (2006) 1.13
Surgical mask to prevent influenza transmission in households: a cluster randomized trial. PLoS One (2010) 1.13
Analysis of IL28B variants in an Egyptian population defines the 20 kilobases minimal region involved in spontaneous clearance of hepatitis C virus. PLoS One (2012) 1.13
Prolonged Plasmodium falciparum infection in immigrants, Paris. Emerg Infect Dis (2008) 1.10
Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study. Am J Hematol (2014) 1.10
Explaining rapid reinfections in multiple-wave influenza outbreaks: Tristan da Cunha 1971 epidemic as a case study. Proc Biol Sci (2011) 1.10
Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France. J Hepatol (2012) 1.09
The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model. Value Health (2007) 1.08
Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome. J Infect Dis (2006) 1.08
Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression. Proc Natl Acad Sci U S A (2011) 1.07
Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. J Hepatol (2011) 1.06
Predicting pneumonia and influenza mortality from morbidity data. PLoS One (2007) 1.05
Adequate wound care and use of bed nets as protective factors against Buruli Ulcer: results from a case control study in Cameroon. PLoS Negl Trop Dis (2011) 1.04
Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study. BMC Infect Dis (2006) 1.04
Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02. J Hepatol (2008) 1.04
Regulatory dysfunction of the interleukin-7 receptor in CD4 and CD8 lymphocytes from HIV-infected patients--effects of antiretroviral therapy. J Acquir Immune Defic Syndr (2006) 1.03
Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009. PLoS One (2011) 1.03
Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role? J Acquir Immune Defic Syndr (2007) 1.02
Broad respiratory virus detection in infants hospitalized for bronchiolitis by use of a multiplex RT-PCR DNA microarray system. J Med Virol (2012) 1.02
Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C. Antivir Ther (2007) 1.01
Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY). AIDS (2007) 1.01
Injection drug use is a risk factor for HCV infection in urban Egypt. PLoS One (2009) 1.00
Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway. J Virol (2010) 1.00
Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso. Trop Med Int Health (2008) 1.00
Litchi-associated acute encephalitis in children, Northern Vietnam, 2004-2009. Emerg Infect Dis (2012) 1.00
Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology (2013) 0.99
Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients. PLoS One (2011) 0.98
Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy. J Acquir Immune Defic Syndr (2005) 0.98
Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level. Eur J Public Health (2003) 0.98
Prevalence and incidence of, and risk factors for, HIV-1 infection among factory workers in Ethiopia, 1997-2001. J Health Popul Nutr (2005) 0.97
Incidence, presentation, and prognosis of small bowel adenocarcinoma in patients with small bowel Crohn's disease: a prospective observational study. Inflamm Bowel Dis (2013) 0.96
Detection of lung cancer on radiographs: receiver operating characteristic analyses of radiologists', pulmonologists', and anesthesiologists' performance. Radiology (2004) 0.96
How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited. Clin Chem (2008) 0.96
Surveillance of acute hepatitis C in Cairo, Egypt. J Med Virol (2005) 0.96